The 8 most recent market catalysts affecting $BDX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 12, 2026
Corporate Catalyst
Bullish
Impact 55
Becton, Dickinson And Co. Completes Enrollment In PREVENT Clinical Trial Evaluating Phasix Mesh For Prevention Of Incisional Hernias
BD (Becton, Dickinson and Company) has completed patient enrollment in its PREVENT clinical trial, which is evaluating Phasix Mesh for the prevention of incisional hernias. This is…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 55
Citigroup Maintains Buy on Becton Dickinson, Raises Price Target to $204
Citigroup analyst Joanna Wiensch maintained a 'Buy' rating on Becton Dickinson and raised the price target from $198 to $204. This action signals continued confidence in the compan…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 55
Wells Fargo Maintains Equal-Weight on Becton Dickinson, Raises Price Target to $170
Wells Fargo analyst Lawrence Biegelsen reiterated an 'Equal-Weight' rating on Becton Dickinson (BDX) but raised the price target from $161 to $170. This action signals a modest inc…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 85
Beckton, Dickinson shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 adjusted EPS guidance above estimates.
This headline is a significant positive catalyst for Beckton, Dickinson (BDX) due to better-than-expected earnings and an upward revision of future guidance. This indicates strong …
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 85
Becton Dickinson Signals Strong Growth Momentum By Raising Profit Outlook
Becton Dickinson (BDX) significantly outperformed analyst expectations for both Q3 adjusted earnings and sales, demonstrating robust growth across its diverse medical technology se…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Hold on Becton Dickinson, Raises Price Target to $182
TD Cowen analyst Joshua Jennings maintained a 'Hold' rating on Becton Dickinson (BDX) but raised the price target from $163 to $182. This action reflects a slightly improved outloo…
Jul 28, 2026
Corporate Catalyst
Neutral
Impact 55
UBS Initiates Coverage On Becton Dickinson with Buy Rating, Announces Price Target of $190
UBS analyst Patrick Wood initiated coverage on Becton Dickinson (BDX) with a 'Buy' rating and set a price target of $190. This event signals a new institutional endorsement of the …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.